| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |